Hologic

Hologic has completed its purchase of San Diego cancer testing company Biotheranostics, Inc., the Marlborough medical technology company announced late Monday.

A new study has demonstrated the safety and clinical effectiveness of a device Hologic is developing to aid with breast surgery.

Marlborough medical device company Hologic will soon integrate Google Cloud’s machine learning technologies into its Genius Digital Diagnostics system, which helps doctors screen for cervical cancer, Hologic announced on Monday.

Marlborough medical technology device company Hologic announced on Tuesday a nearly 90% increase in revenue in the first quarter of 2021, resulting in $1.18 billion in gross profit.

Hologic is continuing its acquisition spree with an agreement to purchase San Diego cancer test firm Biotheranostics for $230 million, the Marlborough company announced late on Monday.

Hologic has paid $64 million to buy a German biopsy health technology firm, the Marlborough medical device maker said Monday, giving it the second acquisition of roughly that size in the past five months.

For a short stretch early on when the coronavirus pandemic began spreading, the American stock market took a nosedive. In almost all the time since, the stock market, including most of the largest public companies in Central Massachusetts, spent 2020 recovering — and then some.

Marlborough medical device company Hologic has added 3D imaging to its SuperSonic MACH 40 ultrasound system. 

Marlborough medical device company Hologic has won regulatory approval for a new device using artificial intelligence to detect subtle potential breast cancers.

Hologic has won U.S. Food and Drug Administration approval for an HIV test the Marlborough manufacturer says is the first in the country that can be used for both diagnosis and viral load monitoring.